shivering
Conditions
Interventions
The placebo group:0.9% saline 250 ml was intravenously administered over 30 minutes
The ibuprofen group:Ibuprofen 10mg/kg (250ml) was intravenously administered over 30 minutes
Sponsors
Department of Anesthesiology, Obstetrics and Gynecology Hospital affiliated to Fudan University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) ASA < III; (2) Aged 20-60 years; (3) Indices of cardiac, liver, kidney, blood and other examinations are in the normal range; (4) According to GCP, all volunteers sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) primary disease of important organs, such as cardiovascular and cerebrovascular diseases, hyperthyroidism, and neuromyopathy. (2) mentally or physically disabled; (3) severe obesity (BMI > 35 kg/m2); (4) a history of gastrointestinal ulcer or gastrointestinal bleeding; (5) allergy to aspirin or other non-steroidal anti-inflammatory drugs; (6) contraindications to neuraxial anaesthesia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of severe early postoperative shivering; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence of severe late postoperative shivering;Body temperature measured at forehead;Cochlear temperature;Body temperature measured at axilla; | — |
Countries
China
Contacts
Public ContactShaoqiang Huang
Department of Anesthesiology, Obstetrics and Gynecology Hospital affiliated to Fudan University
Outcome results
None listed